A trial vaccine is being touted as the most promising treatment to date for melanoma that has spread, with increased patient survival rates and improved ability to stop or reverse the cancer, according to a study published in the Journal for ImmunoTherapy of Cancer.

Of all the diseases that are developing resistance to antibiotics, pulmonary tuberculosis (TB) is by far the largest killer. One-and-a-half million people die of the disease each year, about one-quarter from co-infection with HIV.

The heated battle between Australia’s anti-vaccine lobby, the Australian Vaccination Network, and those fighting against its misinformation has taken a positive turn with the New South Wales Department of Fair Trading ordering the AVN to change its name or risk being shut down.

A trial vaccine is being touted as the most promising treatment to date for melanoma that has spread, with increased patient survival rates and improved ability to stop or reverse the cancer, according to a study published in the Journal for ImmunoTherapy of Cancer.

Of all the diseases that are developing resistance to antibiotics, pulmonary tuberculosis (TB) is by far the largest killer. One-and-a-half million people die of the disease each year, about one-quarter from co-infection with HIV.